MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cancer cell stemness.
Journal Information
Full Title: Br J Cancer
Abbreviation: Br J Cancer
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Competing interests We declare that we have no potential financial conflict of interest related to this manuscript. None of the material in this work has been published or is under consideration for publication elsewhere."
"Funding PC is supported by INSERM Cancer (REMOTE project), Université Claude Bernard Lyon 1, the 'Project LIA/LEA 2016' (grant no. ASC17018CSA), the Weston Park Cancer Charity (grant no. CA163), and the LabEX DEVweCAN (ANR-10-LABX-61) of the University Lyon 1, within the program 'Investissements d’Avenir' (ANR-11-IDEX-0007) operated by the French National Research Agency (ANR). MC is supported by ‘Ligue Régionale Contre le Cancer (CD71)’. CG is supported by ‘Ligue Nationale contre le Cancer (Label CG)’."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025